Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 46,080 shares of Iqvia stock in a transaction on Friday, December 1st. The shares were sold at an average price of $101.79, for a total transaction of $4,690,483.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Ari Bousbib also recently made the following trade(s):
- On Wednesday, November 1st, Ari Bousbib sold 46,080 shares of Iqvia stock. The shares were sold at an average price of $108.14, for a total value of $4,983,091.20.
- On Monday, October 2nd, Ari Bousbib sold 46,080 shares of Iqvia stock. The shares were sold at an average price of $94.91, for a total value of $4,373,452.80.
Shares of Iqvia Holdings Inc (NYSE:IQV) traded down $0.27 during trading hours on Wednesday, hitting $101.00. The company had a trading volume of 1,012,100 shares, compared to its average volume of 1,504,491. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. The firm has a market cap of $21,316.11, a P/E ratio of 23.12, a price-to-earnings-growth ratio of 1.66 and a beta of 0.61. Iqvia Holdings Inc has a 1 year low of $74.73 and a 1 year high of $110.67.
IQV has been the topic of a number of research reports. BidaskClub lowered Iqvia from a “strong-buy” rating to a “buy” rating in a report on Friday, August 11th. Argus raised their price objective on Iqvia from $98.00 to $104.00 and gave the company a “buy” rating in a report on Monday, September 18th. Royal Bank Of Canada initiated coverage on Iqvia in a report on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 price objective on the stock. KeyCorp restated a “buy” rating and issued a $100.00 price objective on shares of Iqvia in a report on Sunday, September 24th. Finally, Robert W. Baird reiterated a “hold” rating and set a $98.00 price target on shares of Iqvia in a report on Monday, October 9th. Nine investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Iqvia has a consensus rating of “Buy” and an average target price of $105.23.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.